A WHO-UNICEF joint statement encouraging greater health commodity supply chain integration for temperature-sensitive pharmaceuticals where appropriate, 19 November 2020
“Guide to facilitate the implementation of the WHO/UNICEF “Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines” for Africa
t contains action-oriented lists of critical topics to address and checklists tailored to the context of African Union Member States.
...
The contents of this guide aim to guide the development of one comprehensive national deployment and vaccination plan, as proposed and outlined by the guidance – and underlines the need for countries to develop their vaccination plans.
This guide is not meant as a tool to assess deployment readiness. The recommendation to Member States is to use the VIRAT/VRAF 2.0 tool for that, which builds on the COVAX Vaccine Introduction Readiness Assessment Tool (VIRAT) and the World Bank’s Vaccine Readiness Assessment Framework (VRAF).
more
À mesure que la vaccination anti-COVID-19 se met en place à travers le monde, beaucoup de gens demandent à quoi il faut s’attendre, en particulier si les vaccins sont sûrs. La réponse est oui, mais voici quelques informations qui vous seront peut-être utiles.
обновленная версия от 04/10/2021
Информация о введении вакцин
Here you can download different videos: Temperature monitoring; Cold chain; vaccine stock; maintenance; etc.
Die Bundesländer sind für die Organisation der Impfung gegen Corona zuständig. Sie betreiben die Impfzentren, vergeben Termine und planen den Einsatz der mobilen Teams in Pflegeheimen. Hier finden Sie die Infoseite Ihres Bundeslandes zur Corona-Schutzimpfung.
Qu’est-ce qu’un vaccin? Comment fonctionnent les vaccins ARNm contre la COVID-19 et quelle est leur importance? Regardez cette vidéo pour tout savoir sur les vaccins ARNm sûrs et efficaces contre la COViD-19
COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator
The ACT Accelerator is a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
COVAX is co-led by Gavi, the Coalition for Epide...mic Preparedness Innovations (CEPI) and WHO. Its aim is to accelerate the development and manufacture of COVID-19 vaccines, and to guarantee fair and equitable access for every country in the world.
more
Available in English, French, Chinese, Arabic, Russian
8 February 2021
Vaccines are designed to give you immunity without the dangers of getting the disease. It’s common to experience some mild to moderate side effects when receiving vaccinations. This is because your immune system instructs your body to increase blood flow so more immune cells can circulate, and it ...raises your body temperature to kill the virus. Vaccines help protect us against disease and feeling mild or moderate side effects after receiving one is a sign that the vaccine and our immune system is working.
more
12 January 2021
The COVID-19 vaccines under development or approved by regulators are believed to be safe for most people, including people living with HIV.
This document is also available in Arabic and Portuguese.
interim guidance, 19 July 2021 (arabic version)
The following print-only materials are developed to support COVID-19 recommendations. All materials are free for download. They may be printed on a standard office printer, or you may use a commercial printer.
The COVID-19 outbreak poses a significant challenge for all countries – creating an unprecedented need for international solidarity and a coordinated global response. This COVID-19 Partners Platform has launched anew landing platform to be an enabling tool for all countries, implementing partners,... donors and contributors to collaborate in the global COVID-19 response. The Partners Platform features real-time tracking to support the planning, implementation and resourcing of country preparedness and response activities.
more